Overview

Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare the effects of oral roflumilast with placebo on lung function in patients with asthma.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca